JMD Stock Overview
Develops, manufactures, imports, and sells medical devices in Japan and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Japan Medical Dynamic Marketing, INC. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3.46 |
| 52 Week High | JP¥4.80 |
| 52 Week Low | JP¥3.46 |
| Beta | 0.54 |
| 1 Month Change | -6.99% |
| 3 Month Change | -22.07% |
| 1 Year Change | -25.43% |
| 3 Year Change | -75.29% |
| 5 Year Change | -81.40% |
| Change since IPO | -21.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| JMD | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -2.3% | -3.8% | -2.0% |
| 1Y | -25.4% | 15.6% | 6.9% |
Return vs Industry: JMD underperformed the German Healthcare industry which returned 15.6% over the past year.
Return vs Market: JMD underperformed the German Market which returned 6.9% over the past year.
Price Volatility
| JMD volatility | |
|---|---|
| JMD Average Weekly Movement | 3.2% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: JMD has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: JMD's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 511 | Toshiyuki Hironaka | www.jmdm.co.jp |
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects.
Japan Medical Dynamic Marketing, INC. Fundamentals Summary
| JMD fundamental statistics | |
|---|---|
| Market cap | €93.30m |
| Earnings (TTM) | €8.63m |
| Revenue (TTM) | €147.36m |
10.8x
P/E Ratio0.6x
P/S RatioIs JMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JMD income statement (TTM) | |
|---|---|
| Revenue | JP¥24.04b |
| Cost of Revenue | JP¥8.80b |
| Gross Profit | JP¥15.25b |
| Other Expenses | JP¥13.84b |
| Earnings | JP¥1.41b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 53.47 |
| Gross Margin | 63.41% |
| Net Profit Margin | 5.86% |
| Debt/Equity Ratio | 9.6% |
How did JMD perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield26%
Payout RatioDoes JMD pay a reliable dividends?
See JMD dividend history and benchmarks| Japan Medical Dynamic Marketing dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 24 2025 |
| Days until Ex dividend | 95 days |
| Days until Dividend pay date | 183 days |
Does JMD pay a reliable dividends?
See JMD dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 07:34 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Japan Medical Dynamic Marketing, INC. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hidemaru Yamaguchi | Citigroup Inc |
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |
| Motoya Kohtani | Nomura Securities Co. Ltd. |